We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Valtoco was approved for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure. Read More
Janssen made the observation in one of 19 letters filed in response to a request for comments on how OND could promote effective drug development programs. Read More
The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee split yesterday in a 6-6 vote over Durect’s Posirim (bupivacaine extended-release solution) for post-surgical analgesia. Read More
Opioid distribution data recently released by the Drug Enforcement Agency (DEA) shows an additional 24 billion opioid pills were distributed in the U.S. between 2013 and 2014 than was previously known. Read More
The Senate voted 89-10 yesterday to pass the United States-Mexico-Canada trade agreement, sending it to the president’s desk as generic and biologic drug advocates cheered the removal of a 10-year biologic exclusivity provision. Read More
RSS
